Advertisements


Kezar Life Sciences raises $75M in slightly upsized IPO

Kezar Life Sciences Inc. raised $75 million Thursday in an upsized IPO that hit the middle of its price target range. The South San Francisco biotech sold 5 million shares at $15. It was expected to sell 4.7 million shares for between $14 and $16. Insi.....»»

Category: topSource: bizjournalsJun 21st, 2018

Kezar Life Sciences stock jumps 18% after IPO raises $75M

Shares of Kezar Life Sciences Inc. jumped 18 percent on Thursday after it raised $75 million in an upsized IPO that hit the middle of its price target range. The South San Francisco biotech sold 5 million shares at $15. It was expected to sell 4.7 .....»»

Category: topSource: bizjournalsJun 21st, 2018

Kezar Life Sciences sees KZR-261 IND submission in mid-2021

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 12th, 2021

Kezar Life Sciences reports Q1 EPS (25c), consensus (24c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 12th, 2021

Kezar Life Sciences management to meet virtually with Truist

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 21st, 2021

Startup using psychedelics to treat brain injuries raises more funding, plans to go public

A Chicago life sciences startup led by a former Blackhawks player that uses "magic mushrooms" to treat brain injuries is preparing to go public in Canada. Wesana, founded by two-time Stanley Cup champion Daniel Carcillo, announced Wednesday that .....»»

Category: topSource: bizjournalsMar 31st, 2021

Kezar Life Sciences management to meet virtually with Jefferies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 15th, 2021

Kezar Life Sciences reports Q4 EPS (22c), consensus (23c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 11th, 2021

Kezar Life Sciences reports Q1 EPS (30c), consensus (38c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 7th, 2020

Kezar Life Sciences participates in a conference call hosted by SunTrust

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 6th, 2020

Kezar Life Sciences price target lowered to $9 from $15 at H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 5th, 2020

Kezar Life Sciences appoints Noreen Henig, MD as Chief Medical Officer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 4th, 2020

Kezar Life Sciences expects cash to fund company into 3Q22

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 9th, 2020

Kezar Life Sciences on track for IND application for KZR-261 in 1Q21

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 9th, 2020

Kezar Life Sciences anticipates delays in milestones for KZR-616

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 9th, 2020

Kezar Life Sciences 16.115M share Spot Secondary priced at $2.60

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 31st, 2020

Kezar Life Sciences $40M Spot Secondary price range $2.50-$2.60

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 30th, 2020

Kezar Life Sciences files to sell common stock, pre-funded warrants

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 30th, 2020

Kezar Life Sciences files to sell common stock, no amount given

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 30th, 2020

Blackstone raises three-quarters of targeted $4.6 billion life sciences fund

U.S. private equity firm Blackstone Group Inc has secured $3.4 billion from investors for its first fund dedicated to investments in the life sciences sector, targeting $4.6 billion in total, a regulatory filing showed on Thursday......»»

Category: topSource: reutersJan 9th, 2020

South Jersey health care startup raises $3.5 million

A South Jersey life sciences company developing a blood test for the early detection of Alzheimer's and Parkinson's disease, when treatments are likely to be more effective, has raised $3.5 million in equity financing. The private stock sale was dis.....»»

Category: topSource: bizjournalsDec 23rd, 2019